Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 12: 803-807, 1966;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blumberg, A. G.
Right arrow Articles by Vassiliades, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blumberg, A. G.
Right arrow Articles by Vassiliades, J.

Clinical Chemistry, Vol 12, 803-807, Copyright © 1966 by the American Association for Clinical Chemistry

The Interference of Chlorpromazine Metabolites in the Analysis of Urinary Methoxy-Catecholamines

Arnold G. Blumberg 1, Audre M. Heaton 1, and John Vassiliades 1

1 Division of Medical Services, Hillside Hospital, Glen Oaks, N. Y. 11004.

The analysis of urinary methoxy-catecholamines by the method of Pisano (1) could not be applied to the urine of patients who were receiving chlorpromazine. Chlor-promazine and the chlorpromazine metabolites, 7-hydroxychlorpromazine and chlor-promazine sulfoxide, were shown to interfere with the column chromatographic separation and spectrophotometric analysis of the methoxy-catecholamines.

Submitted on May 26, 1966
Accepted on July 14, 1966






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1966 by the American Association for Clinical Chemistry.